Director, Clinical Development
-
Science
Job Description & How to Apply Below
Tonix Pharmaceuticals
* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg).
Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-Borrelia
OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit and follow the Company on Linked In and X .
* Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication.
Zembrace Sym Touch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.
Position OverviewThe Director, Clinical Development provides medical and scientific leadership across clinical development programs, supporting the design, execution, and oversight of clinical trials from Phase 1 through Phase
3. This role combines strategic clinical development responsibilities with hands‑on medical monitoring to ensure patient safety, scientific integrity, regulatory compliance, and high-quality clinical data.
The Director serves as the primary Medical Monitor for assigned studies, providing timely medical guidance to investigators, clinical sites, CROs, and internal study teams. Working closely with Clinical Operations, Pharmacovigilance, Biostatistics, Data Management, Regulatory Affairs, and other cross‑functional partners, this individual contributes to clinical development strategy while maintaining direct involvement in study execution, safety oversight, and emerging clinical data.
Guided by Tonix's core values of integrity, commitment, innovation, and passion, the Director applies sound clinical judgment, scientific expertise, and collaborative leadership to advance development programs and support the delivery of innovative therapies to patients.
Key Responsibilities Clinical Development and Study Strategy- Provide medical and scientific leadership in the strategic planning, design, and execution of clinical development programs from Phase 1 through Phase 3.
- Contribute to clinical development strategies, study design, and future clinical program planning to support organizational objectives.
- Provide medical and scientific input into clinical trial protocols, eligibility criteria, endpoints, study assessments, and other measures supporting patient safety and scientific integrity.
- Collaborate with cross‑functional teams, including Clinical Operations, Regulatory Affairs, Biostatistics, Data Management, Pharmacovigilance, Nonclinical, CMC, and Commercial, to align clinical development activities with program objectives.
- Review and interpret clinical trial results to support development decisions, regulatory strategies, and future studies.
- Serve…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction